tiprankstipranks
Trevi Therapeutics Inc (TRVI)
NASDAQ:TRVI
US Market

Trevi Therapeutics (TRVI) Similar Stocks

Compare
421 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Trevi Therapeutics
$4.60
$428.96M
84.74%
7 Buy
0 Hold
0 Sell
Strong Buy
Cytokinetics
$50.26
$6.03B
-33.51%
14 Buy
1 Hold
0 Sell
Strong Buy
Neurocrine
$120.69
$11.58B
35.28
-7.62%
17 Buy
5 Hold
0 Sell
Strong Buy
SAGE Therapeutics
$7.31
$439.59M
-67.15%
2 Buy
13 Hold
0 Sell
Hold
Xenon
$39.73
$3.00B
-18.64%
7 Buy
0 Hold
0 Sell
Strong Buy
Axsome Therapeutics
$137.75
$6.30B
71.18%
18 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
TRVI
Trevi Therapeutics
4.60
2.11
84.74%
CYTK
Cytokinetics
50.26
-27.76
-35.58%
NBIX
Neurocrine
120.69
-13.49
-10.05%
SAGE
SAGE Therapeutics
7.31
-14.70
-66.79%
XENE
Xenon
39.73
-9.73
-19.67%
AXSM
Axsome Therapeutics
137.75
58.81
74.50%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis